ARTICLE | Company News
Akesis endocrine news
January 26, 2009 8:00 AM UTC
Akesis will file for Chapter 7 bankruptcy after discontinuing development of AKP-020, its sole clinical program. The vanadium insulin-enhancer was in Phase IIa testing to treat Type II diabetes. The c...